Monique Moseley
Nurse Practitioner · Albany, GANPI 1336378280
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$619
- Bayer$574
- Lilly USA, LLC$444
- Novo Nordisk$272
- E.r. Squibb & Sons, L.L.C.$208
- Sumitomo Pharma America, Inc.$164
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,950100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 19 | $619 |
| Bayer | 29 | $574 |
| Lilly USA, LLC | 38 | $444 |
| Novo Nordisk | 16 | $272 |
| E.r. Squibb & Sons, L.L.C. | 13 | $208 |
| Sumitomo Pharma America, Inc. | 9 | $164 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $151 |
| AstraZeneca | 6 | $119 |
| Abbott | 6 | $113 |
| Merck | 7 | $111 |
| Shield Therapeutics Inc | 6 | $110 |
| Boehringer Ingelheim | 5 | $96 |
| Daiichi Sankyo Inc. | 5 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $79 |
| Ardelyx, Inc. | 4 | $76 |
| Johnson & Johnson | 5 | $71 |
| Pfizer | 4 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| AbbVie | 4 | $63 |
| Amgen | 4 | $61 |
| Phathom Pharmaceuticals, Inc. | 4 | $53 |
| Corcept Therapeutics | 3 | $49 |
| Dexcom, Inc. | 2 | $48 |
| GSK | 3 | $48 |
| Organogenesis Inc. | 1 | $22 |
| Seqirus USA Inc | 1 | $19 |
| Teleflex LLC | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $17 |
| UCB, Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$3,950 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $35,746 |
| FarxigaDapagliflozin Propanediol | 14 | $12,497 |
| JardianceEmpagliflozin | 16 | $11,684 |
| LinzessLinaclotide | 12 | $10,882 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $10,613 |
| OzempicSemaglutide | 11 | $9,879 |
| MyrbetriqMirabegron | 14 | $9,152 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $1,300 |
| Nifedipine ErNifedipine | 40 | $1,067 |
| Azelastine Hcl | 46 | $721 |
| Amlodipine Besylate | 134 | $682 |
| Atorvastatin Calcium | 93 | $670 |
| Famotidine | 42 | $562 |
| Fluticasone Propionate | 53 | $545 |
| Pioglitazone Hcl | 32 | $535 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $65 | $35,74634 claims |
| AstraZenecaFarxiga | $119 | $12,49714 claims |
| Boehringer IngelheimJardiance | $96 | $11,68416 claims |
| AbbVieLinzess | $63 | $10,88212 claims |
| GSKTrelegy Ellipta | $48 | $10,61313 claims |
| Novo NordiskOzempic | $272 | $9,87911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Albany
- Elizabeth TyeAlbany$78K
- Mary HockmanAlbany$10K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Jessica AdkinsSavannah$226K
- Janice McAlisterAtlanta$221K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Luis PoloSavannah$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.